Soliton Completes Treatment of All Patients in Pivotal Cellulite Trial
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Nov 19
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed
05 Nov 19
The device is the first of Its kind biomaterial poised to disrupt the PEEK and titanium implant market
05 Nov 19
TTP Ventus has extended its BL and XP Series with four additional pumps. These provide increased flow rates…
28 Oct 19
Interim results presented at American Society for Dermatologic Surgery annual meeting
28 Oct 19
Sebacia Microparticles is used with 1064nm lasers in photothermal heating of sebaceous glands to treat inflammatory acne vulgaris
25 Oct 19
FMCNA’s new haemodialysis system has been designed to prevent blood clotting in patients without the use of blood…
25 Oct 19
The LBR iiwa allows humans and robots to work in close cooperation on highly sensitive tasks, such as…
23 Oct 19
Phillips-Medisize is responsible for providing commercialisation services from its manufacturing site in Hudson, Wisconsin, US, following receipt of…
23 Oct 19
Hatteras Venture Partners is a venture capital firm based in Durham, N.C., with a focus on seed and…
22 Oct 19
This award will develop and evaluate a variation of the Case for Quality Voluntary Improvement Program pilot (CfQ…